LVIP Franklin Templeton Multi-Factor International Equity Fund's Novo Nordisk AS Holding Summary
As of 2025-03-31, LVIP Franklin Templeton Multi-Factor International Equity Fund held 198,930.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr13.60 Mil. This investment constitutes 1.59% of their stock portfolio, and LVIP Franklin Templeton Multi-Factor International Equity Fund now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2023Q2. And since then LVIP Franklin Templeton Multi-Factor International Equity Fund has made 3 purchases of OCSE:NOVO B, at an average price of kr561.79, for a total of 298,771.00 shares. In addition, there have been 5 sales at an average price of kr723.71 for 99,841.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr443.05, LVIP Franklin Templeton Multi-Factor International Equity Fund's estimated gain on his OCSE:NOVO B holdings is kr-7.46 Mil, reflecting a -4.44% gain to date.
LVIP Franklin Templeton Multi-Factor International Equity Fund OCSE:NOVO B (kr443.05) Holding Chart
LVIP Franklin Templeton Multi-Factor International Equity Fund OCSE:NOVO B (kr443.05) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
